Tomoko Inoue

Founder and Representative Director

2024 - Current

A Venture Capital Firm Specializing in Deep Tech Investments with a Focus on Healthcare

Chief Executive Officer

2018 - 2024

Running all startup investments of Omron Ventures. https://www.omron.com/omronventures/portfolio/

Senior General Manager, Global Corporate Venturing Office

2022 - 2023

Founding member and Senior Manager

2013 - 2018

As a founding member of MPI from INCJ, the parent company of MedVenture Partners (MPI), supported the foundation of MPI. As an investment professional, sourced deals, executed due diligence, collaborating with global professional teams (Medtech professionals, researchers, universities, lawyers, patent attorneys and other professionals), negotiated for investment contracts and incubated portfolio company’s products. Selected transactions: - Biomedical Solutions, Inc. (a Japanese start-up developing neurothrombectomy devices): As a lead investor in Series A, built the investment scheme, executed due diligence, closed on the contracts. Acquired by JIMRO, Inc., subsidiary of Otsuka Holdings on Feb 2017. - C2 Therapeutics, Inc. (a start-up in Silicon Valley developing a cryoballoon ablation system for ablation of barrett's esophagus) Acquired by Hoya/Pentax medical on Jan. 2017. - ABK Biomedical, Inc. (a Canadian start-up developing radiopaque embolic beads for embolic therapies): Series A investment on June 2016. - Amaranth medical, Inc. (a Silicon Valley start-up developing a fully bioresorbable scaffold): Series C investment on March 2017.

Biodesign Faculty Fellow

2015 - 2015

Vice President

2011 - 2014

Government backed Private Equity firm with investment capacity of $20bn. - Established a new Venture Capital, MedVenture Partners, Inc. to energize the Japanese Medical Device Industry. Created the business model of the new Venture Capital, raised the 6 billion yen fund, streamlined the company structure and materialized the 1st investment of this new VC in 5 months. - Led several cross-border deals to globalize leading Japanese companies. - Executed due diligence, collaborating with global professional teams (FAs, lawyers and consulting firms).

Short Term Consultant

2011 - 2011

Developed an entry strategy to the Japanese market for the portfolio company of European PE firm, the hearing aid device retailer. Materialized the first management meeting with the M&A target company of the portfolio company.

Summer consultant

2010 - 2010

Developed a practical action plan to double the number of incoming tourists in Japan within ten years term.

Summer Intern (IIRP)

2010 - 2010

Created a totally unprecedented business model for the new medical device (automated sedation system for the endoscopic study) developed in J&J, collaborating with 40+ people in Japan and the US and observing the experiments in the hospitals. The business model was the first “pay-as-you-go” business model combining pharmaceutical and the disposable parts of the medical device together.

Vice President

2006 - 2009

Established Japanese Private Equity firm. Sourced deals by negotiating strongly with various stakeholders, and executed deals even in 2008, one of the toughest timing in PE market in Japan. Selected transactions - Showayakuhinkako (Pharmaceutical company): Sourced the deal, negotiated with the seller fund, the management of Showa and various lenders. Upon execution, analyzed the industry and the business and found the opportunity to develop their business even though no one agreed at first. Prepared financial modeling and financing, arranging syndicate investment and loans include mezzanine and LBO and materialized the deal in the reasonable price. Drafted a new business plan with management team and achieved its epoch making sales within a year. - Barneys (Retail): Renewed the license agreement, strategized a new outlet business model opening two outlet stores, and concluded an agreement with licenser, Barneys New York for drastic business model change.